Diamedica Therapeutics financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

디아메디카 테라퓨틱스NASDAQ:DMAC · Nasdaq · Healthcare

$8.23-1.44%

2026-10-02 close

Diamedica Therapeutics's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$27M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy